Skip to main content
. 2016 Aug 16;6:31179. doi: 10.1038/srep31179

Table 2. Panel of monoclonal antibodies to identify minimal residual disease.

Test-tube FITC PE PerCP APC
1 CD45 (20 uL) CD10 (15 uL) CD34 (15 uL) CD19 (4 uL)
2 CD45 (20 uL) IgG-1 (15 uL) CD34 (15 uL) CD19 (4 uL)
3 Syto-13®* CD19 (4 uL)

*SYTO® 13 Green Fluorescent Nucleic Acid Stain: molecular probe from Invitrogen used to assess cell viability. All antibodies were purchased from Biotech, Exbio.